Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
MaxCyte ( (MXCT) ) has provided an update.
MaxCyte, Inc., a non-UK issuer, has announced a change in its major holdings as BlackRock, Inc. has adjusted its voting rights in the company. BlackRock’s resulting position after crossing the threshold on February 10, 2025, is 6.78% of voting rights attached to shares and 0.86% through financial instruments, totaling 7.64%. This adjustment reflects a slight shift from their previous notification, affecting the distribution of voting influence in MaxCyte, which may impact its strategic decisions and stakeholder engagement.
More about MaxCyte
YTD Price Performance: 2.47%
Average Trading Volume: 52,173
Technical Sentiment Consensus Rating: Hold
Current Market Cap: £355.7M
Learn more about MXCT stock on TipRanks’ Stock Analysis page.
